J Greenfield, LM Metz, A Khakban,
ER Llorian… - Multiple Sclerosis and …, 2023 - Elsevier
Background Long-term population-based safety studies are needed to investigate cancer
outcomes in people with multiple sclerosis (MS) treated with modern disease-modifying …